Loading clinical trials...
Loading clinical trials...
Evaluation of Clinical and Immunological Parameters in Children Treated With Subcutaneous Immunotherapy Towards Pollen - a Controlled Study
Conditions
Interventions
Subcutaneous immunotherapy with ALK Alutard birch or ALK Alutard timothy
No immunotherapy, symptomatic treatment
Locations
1
Sweden
Karolinska University Hospital
Stockholm, Sweden
Start Date
May 1, 2017
Primary Completion Date
January 31, 2022
Completion Date
January 31, 2022
Last Updated
April 5, 2022
NCT06979323
NCT06664619
NCT07431021
NCT07383896
NCT07356310
NCT07282886
Lead Sponsor
Karolinska Institutet
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions